Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
You don’t have to lift heavy weights or do interval training to decrease side effects related to cancer treatment.
New research shows that gene activity could be used to predict tumors most likely to benefit from “genotoxic” therapies
The Melanoma Research Alliance presents a Perspective in Cancer Cell, which identifies challenges in melanoma research and drug discovery
The fund will help to develop initiatives to support researchers of color and increase diversity in cancer research and patient care.
After approval of the latest cellular therapy for non-Hodgkin lymphoma, the big challenge is how to extend it to common solid tumors.
“This is the fight of our lives, and we will never stop working to end this disease,” the first lady told the National Cancer Institute.
The Melanoma Research Alliance shares the top five items that has our team excited for the coming year in the fight against melanoma.
Multiple oral sex partners are also linked to oral cancers, but the answer isn’t abstinence—it’s the HPV vaccine.
The Damon Runyon Cancer Research Foundation awards $2.8 million to innovative early career scientists.
The National Cancer Institute discusses the progress of the Cancer Moonshot to accelerate cancer research.
The AACR acknowledges May as National Cancer Research Month.
Damon Runyon Cancer Research Foundation shares some exciting discoveries made by Damon Runyon researchers in 2020.
Precision techniques are becoming more broadly applied for men with advanced prostate cancer.
The FDA-approved test determines both whether prostate cancer has metastasized and where those tumor cells can be found.
Discovery Science Driving Clinical Breakthroughs Week 2
The loss of a child appears to be a mortality risk factor for people diagnosed with cancer.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.